Why Baxter (BAX) Is Up 23.4% After Raising 2026 Outlook Despite Weaker First-Half Profitability

Baxter International Inc. (BAX) saw its stock rise 23.4% after reporting increased Q2 2026 sales and net income, leading to an upgraded full-year sales and earnings guidance for continuing operations. Despite this, first-half 2026 net income was lower year-over-year, indicating persistent early-year profitability pressures. The company's raised sales outlook to 3-4% growth signals a potential revenue recovery, but investors are advised to monitor ongoing margin compression.